A european Phase III, multicentre, double-blind, randomised, monotherapy, 12-month study of Minalcipran for the treatment of the Fibromyalgia Syndrome
A european Phase III, multicentre, double-blind, randomised, monotherapy, 12-month study of Minalcipran for the treatment of the Fibromyalgia Syndrome
A european Phase III, multicentre, double-blind, randomised, monotherapy, 12-month study of Minalcipran for the treatment of the Fibromyalgia Syndrome
Status
Status :
Completed
Type of study
Phase III
Min. Age
18
Years old
Max. Age
71
Years old
Gender
All
Therapeutic area :
Central Nervous System
Disease :
Fibromyalgia
Study medication :
Milnacipran
Phase :
Phase III
Start Date :
September 19, 2006
End date :
October 02, 2008
Study ID :
F02207 GE 304
EudraCT/CTIS number :
2006-001230-41
Send by email